Literature DB >> 15661876

Enhanced production of IL-10 by dendritic cells deficient in CIITA.

Christina S K Yee1, Yongxue Yao, Qi Xu, Brian McCarthy, Deqin Sun-Lin, Masahide Tone, Herman Waldmann, Cheong-Hee Chang.   

Abstract

Dendritic cells (DC) are professional APCs that play a critical role in regulating immunity. In DC, maturation-induced changes in MHC class II expression and Ag presentation require transcriptional regulation by CIITA. To study the role of CIITA in DC, we evaluated key cell functions in DC from CIITA-deficient (CIITA(-/-)) mice. The ability to take up Ag, measured by fluid phase endocytosis, was comparable between CIITA(-/-) and control DC. Although CIITA(-/-) DC lack MHC class II, they maintained normal expression of costimulatory molecules CD80, CD86, and CD40. In contrast, CIITA(-/-) DC activated with LPS or CpG expressed increased IL-10 levels, but normal levels of TNF-alpha and IL-12 relative to control. Enhanced IL-10 was due to greater IL-10 mRNA in CIITA(-/-) DC. Abeta(-/-) DC, which lack MHC class II but express CIITA normally, had exhibited no difference in IL-10 compared with control. When CIITA was cotransfected with an IL-10 promoter-reporter into a mouse monocyte cell line, RAW 264.7, IL-10 promoter activity was decreased. In addition, reintroducing CIITA into CIITA(-/-) DC reduced production of IL-10. In all, these data suggest that CIITA negatively regulates expression of IL-10, and that CIITA may direct DC function in ways that extend beyond control of MHC class II.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661876     DOI: 10.4049/jimmunol.174.3.1222

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.

Authors:  Kavita Purnanda Bhat; Agnieszka Dorota Truax; Susanna Fletcher Greer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.

Authors:  Giovanna Butticè; Janice Miller; Lin Wang; Barbara D Smith
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 3.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

4.  CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.

Authors:  Priya Londhe; Bo Zhu; Jinu Abraham; Charles Keller; Judith Davie
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

5.  VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malaria.

Authors:  Miriam Canavese; Tania Dottorini; Andrea Crisanti
Journal:  Pathog Glob Health       Date:  2015-09-21       Impact factor: 2.894

6.  The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis.

Authors:  Yong Xu; Larry Luchsinger; Edgar C Lucey; Barbara D Smith
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-12       Impact factor: 6.914

Review 7.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

8.  UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system.

Authors:  Qiwei Zhang; Yongxue Yao; Raymond L Konger; Anthony L Sinn; Shanbao Cai; Karen E Pollok; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

9.  Human IL10 gene repression by Rev-erbα ameliorates Mycobacterium tuberculosis clearance.

Authors:  Vemika Chandra; Sahil Mahajan; Ankita Saini; Hedwin K Dkhar; Ravikanth Nanduri; Ella B Raj; Ashwani Kumar; Pawan Gupta
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

10.  Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection.

Authors:  Jeremy P Huynh; Chih-Chung Lin; Jacqueline M Kimmey; Nicholas N Jarjour; Elizabeth A Schwarzkopf; Tara R Bradstreet; Irina Shchukina; Oleg Shpynov; Casey T Weaver; Reshma Taneja; Maxim N Artyomov; Brian T Edelson; Christina L Stallings
Journal:  J Exp Med       Date:  2018-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.